Showing codes C9159 (Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity) — C9292 (Injection, pertuzumab, 10 mg)
C9159 - Inj, balfaxar, per i.u
Long description: Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9160 - Inj daxibotulinumtoxina-lanm
Long description: Injection, daxibotulinumtoxina-lanm, 1 unit
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9161 - Inj, aflibercept hd, 1 mg
Long description: Injection, aflibercept hd, 1 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9162 - Inj, avacincaptad peg 0.1 mg
Long description: Injection, avacincaptad pegol, 0.1 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9163 - Inj talquetamab-tgvs 0.25 mg
Long description: Injection, talquetamab-tgvs, 0.25 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9164 - Cantharidin top, applicator
Long description: Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9165 - Inj, elranatamab-bcmm, 1 mg
Long description: Injection, elranatamab-bcmm, 1 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9166 - Injection, secukinumab
Long description: Injection, secukinumab, intravenous, 1 mg
Code added date: 20240401.
Code effective date: 20240701.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9167 - Inj, adzynma, 10 iu
Long description: Injection, adamts13, recombinant-krhn, 10 iu
Code added date: 20240401.
Code effective date: 20240701.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9168 - Injection, mirikizumab-mrkz
Long description: Injection, mirikizumab-mrkz, 1 mg
Code added date: 20240401.
Code effective date: 20240701.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9169 - Inj, nogapendekin pmln 1 mcg
Long description: Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
Code added date: 20241001.
Code effective date: 20250101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9170 - Inj, tarlatamab-dlle, 1 mg
Long description: Injection, tarlatamab-dlle, 1 mg
Code added date: 20241001.
Code effective date: 20250101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9171 - Inj, pegulicianine, 1 mg
Long description: Injection, pegulicianine, 1 mg
Code added date: 20241001.
Code effective date: 20250101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9172 - Inj, beqvez, per tx dose
Long description: Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
Code added date: 20241001.
Code effective date: 20250101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9173 - Inj, nypozi, 1 mcg
Long description: Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
Code added date: 20250101.
Code effective date: 20250701.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9174 - Datopotamab deruxtecan, 1 mg
Long description: Injection, datopotamab deruxtecan-dlnk, 1 mg
Code added date: 20250701.
Code effective date: 20251001.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9175 - Inj, treosulfan, 50 mg
Long description: Injection, treosulfan, 50 mg
Code added date: 20250701.
Code effective date: 20251001.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9248 - Inj, clevidipine butyrate
Long description: Injection, clevidipine butyrate, 1 mg
Code added date: 20090101.
Code effective date: 20251001.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9250 - Artiss fibrin sealant
Long description: Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
Code added date: 20090701.
Code effective date: 20170101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9254 - Injection, lacosamide
Long description: Injection, lacosamide, 1 mg
Code added date: 20100101.
Code effective date: 20100101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9257 - Bevacizumab injection
Long description: Injection, bevacizumab, 0.25 mg
Code added date: 20100101.
Code effective date: 20100101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9275 - Hexaminolevulinate hcl
Long description: Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
Code added date: 20110101.
Code effective date: 20190101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9279 - Injection, ibuprofen
Long description: Injection, ibuprofen, 100 mg
Code added date: 20110101.
Code effective date: 20130101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9285 - Patch, lidocaine/tetracaine
Long description: Lidocaine 70 mg/tetracaine 70 mg, per patch
Code added date: 20110701.
Code effective date: 20140101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9286 - Injection, belatacept
Long description: Injection, belatacept, 1 mg
Code added date: 20111001.
Code effective date: 20130101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9287 - Inj, brentuximab vedotin
Long description: Injection, brentuximab vedotin, 1 mg
Code added date: 20120101.
Code effective date: 20130101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9288 - Inj, centruroides (scorpion)
Long description: Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial
Code added date: 20120401.
Code effective date: 20130101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9289 - Inj, erwinia chrysanthemi
Long description: Injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.)
Code added date: 20120401.
Code effective date: 20130101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9290 - Inj, bupivacaine liposome
Long description: Injection, bupivacaine liposome, 1 mg
Code added date: 20120401.
Code effective date: 20250101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9291 - Injection, aflibercept
Long description: Injection, aflibercept, 2 mg vial
Code added date: 20120401.
Code effective date: 20120701.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF
C9292 - Injection, pertuzumab
Long description: Injection, pertuzumab, 10 mg
Code added date: 20121001.
Code effective date: 20140101.
Pricing Indicator Code(s):
53
; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML
PDF